DOSE-EFFECT AND STRUCTURE-FUNCTION-RELATIONSHIPS IN DOXORUBICIN CARDIOMYOPATHY
DOSE-EFFECT AND STRUCTURE-FUNCTION-RELATIONSHIPS IN DOXORUBICIN CARDIOMYOPATHY
复制标题
DOI:
10.1016/0002-8703(81)90096-x
复制
发表时间:
1981-01-01
影响因子:
4.8
通讯作者:
DANIELS, JR
中科院分区:
文献类型:
--
作者:
BRISTOW, MR;MASON, JW;DANIELS, JR
Cardiomyopathy (CM) produced by the anticancer drug doxorubicin (DXR) (adriamycin) provides a unique opportunity to analyze dose-effect and structure-function relationships during development of myocardial disease. The degree of morphologic damage was measured by ultrastructural examination of endomyocardial biopsy and the degree of performance abnormality by right heart catheterization in patients receiving DXR. Morphologic damage was variable but was proportional to the total cumulative DXR dose between 100 and 600 mg/m2. Performance abnormalities correlated weakly with dose, exhibited a curvilinear relationship and had a threshold for expression. Catheterization abnormalities correlated well with morphologic damage (r = 0.57-0.78) in a subgroup of patients in whom exercise hemodynamics were measured; this relationship also exhibited a curvilinear, threshold configuration. In DXR-CM myocardial damage is proportional to the degree of cytotoxic insult (DXR dose), while myocardial function is preserved until a critical dose or degree of damage is reached, after which myocardial performance deteriorates rapidly.